At a glance
- Originator Asahi Kasei
- Class Antineoplastics; Antivirals; Purine nucleosides; Small molecules
- Mechanism of Action Adenosylhomocysteinase inhibitors; RNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Viral infections
Most Recent Events
- 02 Nov 1994 Discontinued-Preclinical for Viral infections in USA (Unknown route)